- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07662499
Healthy Eating and Active Living (HEAL), Exploring Feasibility of a Lifestyle Intervention (HEAL)
Healthy Eating and Active Living (HEAL): A Single-Arm Feasibility Trial of a Multimodal Lifestyle Intervention on Brain, Metabolic, and Behavioral Health
Lifestyle interventions combining nutrition, physical activity, and behavioral strategies are increasingly recognized for improving metabolic and psychological health, yet their translation into real-world settings remains limited. Key implementation factors such as feasibility, adherence, intervention fidelity, and the integration of complex assessment modalities are often underreported, despite being essential for scaling and clinical application.
The Healthy Eating and Active Living (HEAL) study is a prospective, single-arm feasibility trial evaluating a structured, multimodal lifestyle intervention within a university research environment. The 12-week program integrates supervised progressive resistance training and structured nutritional guidance, delivered through existing infrastructure including the Center for Brain and Health, the Public Health Research Center, on-campus fitness facilities, and digital dietary monitoring tools. The exercise component consists of twice-weekly supervised, machine-based resistance training with standardized progression, while the nutritional component includes four weeks of meal provision followed by guided self-management.
Participants complete a multimodal assessment battery at baseline, post-intervention, and 12-week follow-up, including body composition, blood biomarkers, gut microbiome analysis, fitness testing, wearable-based activity and sleep monitoring, self-reported measures, and resting-state functional magnetic resonance imaging (fMRI).
The primary objective is to assess feasibility, including recruitment, retention, adherence, intervention fidelity, safety, acceptability, and data completeness. Secondary analyses explore pre-post changes in physiological, behavioral, and neuroimaging outcomes to inform future study design. The study is not powered to assess clinical efficacy. Findings will inform the design of larger trials and the application of the HEAL framework in clinical populations.
연구 개요
상태
상세 설명
Lifestyle-related disorders, including metabolic dysfunction, mental health conditions, and neurodegenerative processes, are increasingly recognized as multifactorial in origin, involving complex interactions between behavior, physiology, and environmental exposures. Interventions targeting diet, physical activity, and behavioral patterns have shown promise in improving these outcomes. However, despite growing evidence for their effectiveness, the implementation of comprehensive lifestyle interventions in real-world settings remains limited. Many studies focus on efficacy under controlled conditions but provide insufficient detail on feasibility, adherence, intervention fidelity, and operational demands, all of which are critical for translation into scalable models.
The Healthy Eating and Active Living (HEAL) study was developed as a translational, multidisciplinary lifestyle intervention embedded within a university research environment. The primary aim of the study is not to evaluate clinical efficacy, but to determine whether a structured, multimodal intervention can be delivered with sufficient feasibility, adherence, and operational fidelity to justify progression to larger trials and clinical applications.
This study is designed as a prospective, single-arm feasibility trial conducted over 12 weeks. The intervention integrates supervised progressive resistance training with structured nutritional guidance and incorporates a comprehensive, multimodal assessment battery. The program is delivered using existing institutional infrastructure, including the Center for Brain and Health (CBH), the Public Health Research Center (PHRC), the Core Technologies Platform (CTP), and on-campus fitness facilities. This setting allows evaluation of the intervention under conditions that reflect real-world implementation, rather than highly controlled laboratory environments.
A central design feature of HEAL is the deliberate standardization of its core components to ensure reproducibility and scalability. The exercise component consists of supervised, machine-based resistance training performed twice weekly in 60-minute sessions. Each session follows a fixed sequence of exercises targeting major muscle groups, including leg press, chest press, seated row, glute drive, lat pulldown, walking lunges, and a core exercise. Following a brief familiarization phase, progression is guided by predefined overload criteria, requiring incremental increases in resistance when participants are able to complete target repetitions with correct form. This standardized structure minimizes variability in delivery, facilitates monitoring of adherence and fidelity, and supports consistent implementation across participants.
The nutritional component is designed to combine structured support with gradual transition to self-management. During the initial four weeks, participants receive prepared meals five days per week, tailored to individual maintenance energy requirements calculated using established predictive equations. Meals follow a standardized macronutrient distribution and emphasize minimally processed, nutrient-dense foods with high dietary fiber content. Participants select meals from a predefined menu, ensuring both adherence to nutritional targets and individual preference. Following the meal-provision phase, participants are guided to maintain similar dietary patterns independently for the remaining eight weeks. Dietary intake is monitored using Intake24, an online 24-hour dietary recall system, administered at baseline, post-intervention, and follow-up.
To evaluate feasibility and the operational burden of integrating diverse outcome measures, the study incorporates a comprehensive multimodal assessment battery. Assessments are conducted at baseline (prior to the intervention), immediately post-intervention, and at a 12-week follow-up period. Physiological measures include anthropometry and body composition analysis using bioelectrical impedance. Blood samples are collected to assess metabolic, inflammatory, and lipid biomarkers. Stool samples are obtained for metagenomic analysis of the gut microbiome. Physical fitness is evaluated using a standardized battery including cardiovascular, strength, mobility, and stability tests. Objective activity and sleep data are collected using a wrist-worn wearable device over an eight-day period. Participants also complete validated self-report questionnaires assessing sleep, wellbeing, energy levels, and daily activity patterns. In addition, resting-state functional magnetic resonance imaging (fMRI) is performed to assess brain network connectivity and to evaluate the feasibility of incorporating neuroimaging within a lifestyle intervention.
The primary outcomes of this study relate to feasibility rather than clinical effectiveness. These include recruitment rates, retention across the intervention period, adherence to supervised exercise sessions, fidelity to the prescribed progression protocol, adherence to nutritional guidance, participant acceptability, safety, and completion rates for each component of the assessment battery. Safety is monitored continuously, with documentation of adverse events, including musculoskeletal complaints or nutrition-related issues. Acceptability is assessed qualitatively through participant feedback regarding burden and overall experience.
Secondary outcomes are exploratory and include descriptive changes in physiological, behavioral, and neuroimaging measures across timepoints. These analyses are not intended to establish efficacy but to identify potential signals, inform outcome selection, and support sample size estimation for future studies.
The HEAL study also serves as a foundational model for subsequent applications of the intervention framework. In particular, it informs the development of the HEAL-MS program, which adapts the intervention for individuals with multiple sclerosis within a clinical context. By establishing that the intervention can be delivered with high adherence, acceptable participant burden, and operational feasibility, this study provides essential implementation data to guide future translational and clinical research.
In summary, the HEAL study is designed to address a key gap in lifestyle intervention research by focusing on feasibility, implementation, and scalability within a real-world setting. The integration of standardized intervention components with a comprehensive multimodal assessment framework allows evaluation not only of participant engagement but also of the logistical and operational requirements necessary for broader application. Findings from this study will inform the refinement of the intervention protocol and support progression to larger-scale trials and clinical populations.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Abu Dhabi Emirate
-
Abu Dhabi, Abu Dhabi Emirate, 아랍 에미리트, 111
- New York University Abu Dhabi
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Adults aged 18 to 65 years
- Able to participate in moderate-intensity supervised resistance training
- Willing to comply with the 12-week intervention and associated assessments
- Able to provide biological samples (blood and stool) and complete behavioral assessments
- Able to provide written informed consent
Exclusion Criteria:
- Medical conditions contraindicating moderate resistance training (e.g., uncontrolled cardiovascular, respiratory, or musculoskeletal conditions)
- Current pregnancy or planned pregnancy during the study period
- Participation in another structured lifestyle, nutrition, or exercise intervention during the study period
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 기초 과학
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: HEAL Intervention
Participants underwent a 12-week multimodal lifestyle intervention combining supervised resistance training and structured nutritional guidance.
The exercise component consisted of twice-weekly, 60-minute supervised, machine-based resistance training sessions following a standardized protocol with predefined progression criteria.
The nutritional component included four weeks of meal provision tailored to individual maintenance energy requirements and macronutrient targets, followed by eight weeks of guided self-management.
Participants were encouraged to maintain similar dietary patterns during the self-managed phase.
Dietary intake was monitored using Intake24.
A comprehensive multimodal assessment battery, including physiological, behavioral, and neuroimaging measures, was conducted at baseline, post-intervention, and at a 12-week follow-up.
|
The intervention consisted of a 12-week multimodal lifestyle program integrating supervised resistance training and structured nutritional guidance.
The exercise component involved twice-weekly, 60-min supervised sessions using standardized machine-based resistance training.
Each session followed a fixed sequence targeting major muscle groups and included leg press, chest press, seated row, glute drive, lat pulldown, walking lunges, and one core exercise.
Following a two-week familiarization phase, participants progressed according to predefined overload criteria, with resistance increased when target repetitions were achieved with proper technique.
Sessions concluded with a short period of moderate cardiovascular activity.
The nutritional component included an initial 4-week meal-provision phase, during which participants received meals five days per week tailored to individual maintenance energy requirements (BMR × 1.2) and macronutrient targets (30% P, 40% C, 30% F)
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Feasibility of the multimodal lifestyle intervention
기간: Baseline to end of intervention (12 weeks), with additional assessment of data completeness at 12-week follow-up (24 weeks total)
|
Feasibility will be assessed as the proportion of participants meeting predefined criteria across key domains, including retention rate (% of participants completing the 12-week intervention), exercise adherence (% of scheduled sessions attended), intervention fidelity (% adherence to predefined progression criteria), dietary adherence (% compliance with macronutrient targets assessed via Intake24), safety (incidence of adverse events), and data completeness (% of completed assessments across modalities).
|
Baseline to end of intervention (12 weeks), with additional assessment of data completeness at 12-week follow-up (24 weeks total)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in body fat percentage measured by bioelectrical impedance analysis (InBody 720)
기간: Baseline, 12 weeks, 24 weeks
|
Change in total body fat percentage assessed using the InBody 720 device.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in visceral fat level measured by bioelectrical impedance analysis (InBody 720)
기간: Baseline, 12 weeks, 24 weeks
|
Change in visceral fat level assessed using the InBody 720 device.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in cardiovascular fitness measured by Harvard Step Test Index Score
기간: Baseline, 12 weeks, 24 weeks
|
Cardiovascular fitness assessed using the Harvard Step Test Index Score, calculated from post-exercise recovery heart rate measurements following a standardized stepping protocol.
Scores range from 0 to 100, with higher scores indicating better cardiovascular fitness and recovery capacity.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in composite muscular strength score derived from standardized strength assessments
기간: Baseline, 12 weeks, 24 weeks
|
Muscular strength was assessed using a composite score derived from standardized repetition-based upper- and lower-body strength tests and timed core stability assessments, including push-ups, bodyweight squats, and plank hold duration.
Individual test results were standardized and combined into a single composite muscular strength score.
Higher scores indicate greater muscular strength and endurance.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in C-reactive protein concentration measured from blood samples
기간: Baseline, 12 weeks, 24 weeks
|
C-reactive protein will be measured using standard clinical laboratory assays and reported as concentration in mg/L.
This outcome is exploratory and will be reported separately.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in lipid concentrations measured from blood samples
기간: Baseline, 12 weeks, 24 weeks
|
Blood lipid concentrations, including total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides, will be measured using standard clinical laboratory assays and reported as concentration in mmol/L or mg/dL.
This outcome is exploratory and will be reported separately.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in gut microbiome composition assessed by metagenomic sequencing of stool samples
기간: Baseline, 12 weeks, 24 weeks
|
Change in microbial diversity and composition assessed using stool-based metagenomic analysis.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in sleep duration measured by wearable activity monitor (Axivity)
기간: Baseline, 12 weeks, 24 weeks
|
Change in sleep duration assessed using accelerometry-derived sleep estimates.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in self-reported wellbeing measured by standardized questionnaire scores
기간: Baseline, 12 weeks, 24 weeks
|
Self-reported wellbeing, sleep, and energy levels will be assessed using validated questionnaire instruments administered electronically via the Voxco platform.
Questionnaire scores will be analyzed according to the scoring procedures of each respective instrument.
Higher scores indicate improved wellbeing, sleep quality, and energy levels where applicable.
These outcomes are exploratory and intended to characterize changes in perceived wellbeing over time.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in resting-state functional connectivity measured by functional magnetic resonance imaging (fMRI)
기간: Baseline, 12 weeks, 24 weeks
|
Change in resting-state brain network connectivity assessed using fMRI and analyzed using standard connectivity metrics.
|
Baseline, 12 weeks, 24 weeks
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Bas Rokers, Professor, New York University Abu Dhabi
간행물 및 유용한 링크
유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- HRPP-2024-73
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
라이프 스타일 수정에 대한 임상 시험
-
Cairo University알려지지 않은상악 Class III Modification I 무치악 환자
Multimodal lifestyle intervention (HEAL program)에 대한 임상 시험
-
AdventHealthState of Florida Department of Health모병